Tirzepatide, a recently approved medication, is generating excitement as a groundbreaking treatment for individuals facing type 2 diabetes . Unlike common diabetes drugs , it works through a innovative mechanism, stimulating both GLP-1 and the GIP hormone receptors. Clinical trials have revealed